TGF-β1 production in radiation nephropathy:: role of angiotensin II
TGF-β1 production in radiation nephropathy:: role of angiotensin II
复制标题
DOI:
10.1080/095530099140401
复制
发表时间:
1999-04-01
影响因子:
2.6
通讯作者:
Lianos, EA
中科院分区:
文献类型:
--
作者:
Datta, PK;Moulder, JE;Lianos, EA
Purpose: Angiotensin II receptor antagonists are effective in the prophylaxis of radiation nephropathy. Studies were designed to determine whether TGF-beta 1, a fibrogenic cytokine, plays a role in mediating the protective effect of AII antagonism. These studies explored the time-course of glomerular TGF-beta 1 production in the irradiated kidney, and whether AII mediates TGF-beta 1 production in glomeruli isolated from irradiated rats.Materials and methods: Rats received 20 Gy of bilateral renal irradiation in five fractions and were randomized to receive an AII type 1 receptor antagonist (L-158,809) at 20 mg/l in their drinking water, or no treatment. Drug therapy began 9 days prior to irradiation and continued for the duration of the study.Results: Analysis of renal function showed a significant increase in urinary proteinuria and blood urea nitrogen by 37 days and 63 days after irradiation, respectively. Estimation of glomerular TGF-beta 1 levels by quantitative sandwich enzyme immunoassay technique revealed a significant increase in latent but not active TGF-beta 1 levels at 50 days and 63 days after irradiation. In animals treated with the ATI receptor antagonist, there was a complete elimination in the rise of TGF-beta 1.Conclusions: These studies demonstrate that glomerular TGF-beta 1 production is elevated in the course of radiation nephropathy, and that AII mediates this induction of TGF-beta 1.